Pushkal Garg - Mar 3, 2023 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
CMO & EVP Dev & Med Affairs
Signature
By: /s/ Andrew Mayer, Attorney-in-Fact For: Pushkal Garg
Stock symbol
ALNY
Transactions as of
Mar 3, 2023
Transactions value $
-$3,132,150
Form type
4
Date filed
3/7/2023, 03:07 PM
Previous filing
Mar 1, 2023
Next filing
Apr 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $241K +2.5K +14.35% $96.45 19.9K Mar 3, 2023 Direct F1
transaction ALNY Common Stock Options Exercise $241K +2.5K +12.55% $96.45 22.4K Mar 3, 2023 Direct F1
transaction ALNY Common Stock Sale -$3.61M -18.1K -80.62% $200.00 4.35K Mar 3, 2023 Direct F1
holding ALNY Common Stock 431 Mar 3, 2023 by Managed Account F2
holding ALNY Common Stock 250 Mar 3, 2023 by Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Performance Stock Option 2014 (right to buy) Options Exercise $0 -2.5K -100% $0.00* 0 Mar 3, 2023 Common Stock 2.5K $96.45 Direct F1
transaction ALNY Stock Option (right to buy) Options Exercise $0 -2.5K -100% $0.00* 0 Mar 3, 2023 Common Stock 2.5K $96.45 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022.
F2 Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
F3 Represents shares held in trust, of which the reporting persons spouse is co-trustee. The reporting person disclaims beneficial ownership of these shares, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4 The stock option vested as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date, and were fully vested on December 17, 2018.